Several enzymes can be used as a target for COVID-19 therapeutics including PI3K ̧ mTOR, growth factor receptor, RAF, MAP2K2, FLT3, AXL, AKT, and matrix metalloprotease MMP2 and MMP9. This evidence concerns the gene AKT1 and COVID-19.